Fidelity Investments’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
PA
ACM
CM
CFM
CA
Fidelity Investments's NAUT Position: Q2 2026 in Review
Fidelity Investments increased its Nautilus Biotechnolgy (NAUT) stake by 7.2% in Q2 2026, buying an estimated $634 and bringing the position to 3,583 shares worth $6.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4960.
Fidelity Investments first reported a position in NAUT in Q1 2021 and has held it in 17 quarters since. The position peaked at $5.77M in Q1 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- Fidelity Investments held 3,583 shares of Nautilus Biotechnolgy worth $6.7K as of Q2 2026.
- Fidelity Investments bought 240 Nautilus Biotechnolgy shares in Q2 2026, an estimated $634.
- Nautilus Biotechnolgy made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4960 holding.
- Fidelity Investments first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 17 quarters since.
- Fidelity Investments's Nautilus Biotechnolgy position peaked at $5.77M in Q1 2021.
- 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.